D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
LeMaitre Vascular
LMAT
$2.26B
| $518K | ﹤0.01% |
9,129
-27,796
| -75% | -$1.46M |
|
3352
Invesco S&P 500 GARP ETF
SPGP
$2.22B
| $515K | ﹤0.01% |
+5,255
| New | +$486K |
|
3353
PUT
MP Materials
MP
$7.68B
| $514K | ﹤0.01% |
+25,900
| New | +$442K |
|
3354
Dime Commercial Bancshares
DCOM
$1.77B
| $512K | ﹤0.01% |
19,021
-25,837
| -58% | -$553K |
|
3355
Cable One
CABO
$224M
| $512K | ﹤0.01% |
919
| – | – |
|
3356
United Fire Group
UFCS
$1.32B
| $511K | ﹤0.01% |
25,418
-3,441
| -12% | -$69.8K |
|
3357
Financial Institutions
FISI
$812M
| $509K | ﹤0.01% |
23,878
-16,166
| -40% | -$288K |
|
|
NARI
3358
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $506K | ﹤0.01% |
+7,800
| New | +$470K |
|
3359
iShares US Regional Banks ETF
IAT
$673M
| $506K | ﹤0.01% |
+12,100
| New | +$434K |
|
3360
Gentex
GNTX
$4.88B
| $503K | ﹤0.01% |
15,415
-126,322
| -89% | -$3.9M |
|
3361
MediaAlpha
MAX
$734M
| $503K | ﹤0.01% |
45,144
-26,043
| -37% | -$258K |
|
3362
Powell Industries
POWL
$7.99B
| $503K | ﹤0.01% |
17,070
-4,692
| -22% | -$131K |
|
3363
iShares Core S&P Total US Stock Market ETF
ITOT
$93.5B
| $502K | ﹤0.01% |
+4,766
| New | +$467K |
|
|
GOLD
3364
Gold.com Inc
GOLD
$1.19B
| $501K | ﹤0.01% |
16,573
+3,467
| +26% | +$98.8K |
|
3365
EVgo
EVGO
$220M
| $499K | ﹤0.01% |
+139,500
| New | +$413K |
|
3366
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.2B
| $499K | ﹤0.01% |
+10,710
| New | +$462K |
|
3367
CALL
Murphy USA
MUSA
$11.3B
| $499K | ﹤0.01% |
+1,400
| New | +$507K |
|
3368
Cullinan Oncology
CGEM
$1.07B
| $498K | ﹤0.01% |
48,919
+9,217
| +23% | +$81.7K |
|
3369
Anavex Life Sciences
AVXL
$232M
| $498K | ﹤0.01% |
53,454
+20,913
| +64% | +$144K |
|
|
SMAR
3370
DELISTED
Smartsheet Inc.
SMAR
| $494K | ﹤0.01% |
10,327
-77,053
| -88% | -$3.28M |
|
3371
ICF International
ICFI
$1.45B
| $493K | ﹤0.01% |
3,676
+833
| +29% | +$109K |
|
3372
Novavax
NVAX
$1.23B
| $492K | ﹤0.01% |
102,533
+86,936
| +557% | +$532K |
|
|
ONC
3373
BeOne Medicines Ltd
ONC
$33.8B
| $492K | ﹤0.01% |
+2,727
| New | +$493K |
|
3374
Moelis & Co
MC
$5.04B
| $492K | ﹤0.01% |
8,759
+3,035
| +53% | +$143K |
|
|
NBIS
3375
CALL
Nebius Group N.V.
NBIS
$47.7B
| $491K | ﹤0.01% |
30,000
| – | – |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.